Venus Remedies, 526953, VENUSREM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

305.84
11.51
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

298.29
N/A
0.66

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.48
9.96
20.83

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-6.38
9.49
8.76

PAT CAGR (%)

10 Years
5 Years
3 Years

-3.36
-
-

P:E (Median)

8 Years
5 Years
3 Years

10.46
4.83
8.10

P:BV (Average)

8 Years
5 Years
3 Years

0.43
0.53
0.80

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.67
7.50
6.90

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 148.53 128.77 15.35% 109.45 117.44 -6.80% 124.75 192.64 -35.24% 154.93 136.85 13.21%
Expenses 127.50 121.46 4.97% 102.37 103.21 -0.81% 109.58 164.71 -33.47% 136.68 117.50 16.32%
EBITDA 21.03 7.31 187.69% 7.08 14.23 -50.25% 15.17 27.93 -45.69% 18.25 19.35 -5.68%
EBIDTM 14.16% 5.68% 6.47% 12.12% 12.16% 14.50% 11.78% 14.14%
Other Income 3.24 2.47 31.17% 3.75 1.07 250.47% 1.77 2.97 -40.40% 1.41 1.92 -26.56%
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 8.06 7.36 9.51% 6.97 8.40 -17.02% 8.77 8.46 3.66% 7.57 8.36 -9.45%
PBT 16.21 2.42 569.83% 3.86 6.90 -44.06% 8.17 22.44 -63.59% 12.09 12.91 -6.35%
Tax 8.67 0.00 0 1.25 -0.95 - 0.44 -1.69 - 1.00 -1.68 -
PAT 7.54 2.42 211.57% 2.61 7.85 -66.75% 7.73 24.13 -67.97% 11.09 14.59 -23.99%
PATM 5.08% 1.88% 2.38% 6.68% 6.20% 12.53% 7.16% 10.66%
EPS 5.63 1.81 211.05% 1.95 5.86 -66.72% 5.77 18.01 -67.96% 8.28 10.89 -23.97%

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 155.64 142.45 9.26% 116.90 124.34 -5.98% 139.89 202.56 -30.94% 143.08 129.81 10.22%
Expenses 131.03 136.91 -4.29% 108.80 111.91 -2.78% 126.92 175.26 -27.58% 128.57 112.99 13.79%
EBITDA 24.61 5.54 344.22% 8.10 12.43 -34.84% 12.97 27.30 -52.49% 14.51 16.82 -13.73%
EBIDTM 15.81% 3.89% 6.93% 10.00% 9.27% 13.48% 10.14% 12.96%
Other Income 3.41 2.25 51.56% 3.81 1.22 212.30% 1.79 2.89 -38.06% 1.44 1.96 -26.53%
Interest 0.00 0.00 0 0.15 0.31 -51.61% 0.00 0.03 -100.00% 0.26 0.14 85.71%
Depreciation 8.29 7.56 9.66% 7.22 8.64 -16.44% 8.99 8.71 3.21% 7.80 8.62 -9.51%
PBT 19.73 0.23 8,478.26% 4.54 4.70 -3.40% 5.77 21.46 -73.11% 7.89 10.02 -21.26%
Tax 8.67 0.00 0 1.25 -0.95 - 0.44 -1.69 - 1.00 -1.68 -
PAT 11.06 0.23 4,708.70% 3.29 5.65 -41.77% 5.33 23.15 -76.98% 6.89 11.70 -41.11%
PATM 7.11% 0.16% 2.81% 4.54% 3.81% 11.43% 4.82% 9.01%
EPS 8.27 0.17 4,764.71% 2.46 4.23 -41.84% 3.99 17.32 -76.96% 5.15 8.75 -41.14%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 537.66 575.18 514.62 320.23 301.84 355.07 375.45 402.69 451.88 526.06 461.34 Net Sales Growth -6.61% 11.77% 60.70% 6.09% -14.99% -5.43% -6.76% -10.89% -14.10% 14.03% Cost Of Goods Sold 336.70 375.97 336.68 176.81 181.78 205.42 186.69 194.64 213.05 298.96 263.27 Gross Profit 200.96 199.22 177.94 143.42 120.06 149.65 188.76 208.05 238.82 227.10 198.07 GP Margin 37.38% 34.64% 34.58% 44.79% 39.78% 42.15% 50.28% 51.67% 52.85% 43.17% 42.93% Total Expenditure 476.13 506.36 467.76 277.16 267.55 311.51 328.16 323.14 364.94 392.83 342.85 Power & Fuel Cost - 3.78 3.39 3.41 3.50 3.02 3.08 2.90 3.28 3.11 2.86 % Of Sales - 0.66% 0.66% 1.06% 1.16% 0.85% 0.82% 0.72% 0.73% 0.59% 0.62% Employee Cost - 43.75 35.89 33.79 30.26 27.82 25.02 25.02 27.26 25.57 23.24 % Of Sales - 7.61% 6.97% 10.55% 10.03% 7.84% 6.66% 6.21% 6.03% 4.86% 5.04% Manufacturing Exp. - 25.48 20.63 18.35 18.98 34.28 75.01 58.94 73.60 20.75 19.72 % Of Sales - 4.43% 4.01% 5.73% 6.29% 9.65% 19.98% 14.64% 16.29% 3.94% 4.27% General & Admin Exp. - 15.01 13.76 15.22 9.79 11.86 12.20 10.85 14.36 13.81 11.10 % Of Sales - 2.61% 2.67% 4.75% 3.24% 3.34% 3.25% 2.69% 3.18% 2.63% 2.41% Selling & Distn. Exp. - 42.37 57.40 29.59 23.24 29.11 26.17 30.78 33.39 30.64 22.66 % Of Sales - 7.37% 11.15% 9.24% 7.70% 8.20% 6.97% 7.64% 7.39% 5.82% 4.91% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 22.66 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 61.53 68.82 46.86 43.07 34.29 43.56 47.29 79.55 86.94 133.23 118.49 EBITDA Margin 11.44% 11.96% 9.11% 13.45% 11.36% 12.27% 12.60% 19.75% 19.24% 25.33% 25.68% Other Income 10.17 8.43 17.76 3.58 4.51 1.19 3.10 0.67 0.55 0.41 0.39 Interest 0.00 0.00 12.73 13.05 25.15 35.44 35.87 36.74 40.70 29.29 24.45 Depreciation 31.37 32.58 34.28 31.05 32.95 32.73 39.32 40.47 44.74 38.61 31.76 PBT 40.33 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 Tax 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 Tax Rate 28.17% -9.67% -32.17% -31.31% 4.07% -13.49% 18.39% 60.13% -123.04% 7.27% 8.82% PAT 28.97 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 PAT before Minority Interest 28.97 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.39% 8.52% 10.55% -2.57% -8.98% -7.49% -5.39% 0.30% 1.01% 11.59% 12.39% PAT Growth -40.87% -9.73% - - - - - -73.63% -92.53% 6.65% EPS 21.62 36.56 40.50 -6.14 -20.23 -19.84 -15.10 0.90 3.40 45.49 42.65

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 555.51 598.65 548.12 339.33 321.89 372.41 400.04 418.27 463.99 541.56 468.64 Net Sales Growth -7.29% 9.22% 61.53% 5.42% -13.57% -6.91% -4.36% -9.85% -14.32% 15.56% Cost Of Goods Sold 331.00 385.45 340.79 174.31 181.95 205.08 227.07 238.51 268.94 300.00 262.26 Gross Profit 224.51 213.20 207.33 165.02 139.94 167.33 172.97 179.77 195.05 241.55 206.38 GP Margin 40.42% 35.61% 37.83% 48.63% 43.47% 44.93% 43.24% 42.98% 42.04% 44.60% 44.04% Total Expenditure 495.32 536.54 494.35 298.52 289.37 332.94 349.32 337.11 374.81 403.33 348.53 Power & Fuel Cost - 4.71 4.58 4.73 4.86 4.29 4.14 4.01 3.80 3.38 3.05 % Of Sales - 0.79% 0.84% 1.39% 1.51% 1.15% 1.03% 0.96% 0.82% 0.62% 0.65% Employee Cost - 52.33 46.02 46.02 42.10 39.31 34.27 32.44 32.36 30.45 27.30 % Of Sales - 8.74% 8.40% 13.56% 13.08% 10.56% 8.57% 7.76% 6.97% 5.62% 5.83% Manufacturing Exp. - 31.57 22.86 20.84 21.01 36.10 42.48 15.70 17.29 22.10 20.61 % Of Sales - 5.27% 4.17% 6.14% 6.53% 9.69% 10.62% 3.75% 3.73% 4.08% 4.40% General & Admin Exp. - 16.91 16.45 17.57 11.85 13.52 13.26 11.97 15.67 14.74 11.82 % Of Sales - 2.82% 3.00% 5.18% 3.68% 3.63% 3.31% 2.86% 3.38% 2.72% 2.52% Selling & Distn. Exp. - 45.56 63.64 35.05 27.60 34.65 28.10 34.48 36.75 32.65 23.50 % Of Sales - 7.61% 11.61% 10.33% 8.57% 9.30% 7.02% 8.24% 7.92% 6.03% 5.01% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.50 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 60.19 62.11 53.77 40.81 32.52 39.47 50.72 81.16 89.18 138.23 120.11 EBITDA Margin 10.84% 10.38% 9.81% 12.03% 10.10% 10.60% 12.68% 19.40% 19.22% 25.52% 25.63% Other Income 10.45 8.31 19.63 5.31 6.09 2.39 4.28 2.01 0.68 0.47 0.44 Interest 0.41 0.48 13.02 13.34 25.41 35.56 36.38 37.98 41.21 29.40 24.63 Depreciation 32.30 33.53 35.28 32.01 33.98 33.83 40.26 41.68 46.00 40.22 33.08 PBT 37.93 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 Tax 11.36 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 Tax Rate 29.95% -11.86% -27.21% -24.41% 3.87% -11.48% 21.07% 51.57% -94.72% 6.92% 8.80% PAT 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 PAT before Minority Interest 26.57 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.78% 6.80% 11.27% -2.95% -8.88% -8.24% -4.27% 0.41% 1.11% 11.87% 12.23% PAT Growth -34.77% -34.08% - - - - - -67.05% -91.98% 12.20% EPS 19.83 30.39 46.10 -7.46 -21.32 -22.90 -12.75 1.27 3.85 47.99 42.77

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 449.41 400.18 332.25 340.95 367.99 394.23 444.43 466.24 467.42 392.24 Share Capital 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 11.44 10.54 Total Reserves 436.05 374.09 319.91 328.61 355.65 381.89 432.99 454.79 455.97 376.92 Non-Current Liabilities 45.95 58.81 96.03 136.75 157.89 179.52 212.03 221.50 161.27 147.18 Secured Loans 0.00 0.00 23.92 60.88 86.02 112.69 134.55 150.91 114.28 103.89 Unsecured Loans 38.68 47.52 48.34 55.20 50.84 49.13 56.47 51.34 25.22 25.22 Long Term Provisions 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 3.31 2.91 Current Liabilities 82.61 87.82 215.98 254.46 222.61 193.71 177.59 157.06 207.33 190.06 Trade Payables 49.63 68.36 33.96 33.41 27.19 30.56 23.90 25.76 28.14 17.87 Other Current Liabilities 32.23 18.78 99.99 107.61 76.87 45.70 36.63 13.99 54.12 57.88 Short Term Borrowings 0.00 0.00 81.42 108.92 117.23 115.70 115.09 115.40 110.08 95.68 Short Term Provisions 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 14.99 18.63 Total Liabilities 577.97 546.81 644.26 732.16 748.49 767.46 834.05 844.80 836.02 729.48 Net Block 224.67 244.20 271.47 346.89 369.93 389.38 433.52 425.77 416.09 380.92 Gross Block 578.19 581.73 589.77 674.06 669.01 655.78 660.61 612.50 555.61 481.83 Accumulated Depreciation 353.52 337.53 318.30 327.17 299.08 266.40 227.09 186.73 139.52 100.91 Non Current Assets 313.57 333.08 360.33 478.57 499.96 517.54 575.53 618.72 567.61 500.20 Capital Work in Progress 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 67.80 47.81 Non Current Investment 0.14 0.14 0.14 0.14 0.14 28.74 28.74 28.74 28.74 28.74 Long Term Loans & Adv. 61.96 62.34 64.08 66.78 65.13 33.17 32.90 85.91 54.98 42.74 Other Non Current Assets 1.57 1.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 264.41 213.74 283.94 253.59 248.53 249.93 258.53 226.08 268.41 229.28 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 125.63 119.69 136.44 140.94 135.98 139.69 137.69 140.44 141.46 126.40 Sundry Debtors 30.41 16.44 29.78 31.39 44.15 41.91 53.88 59.37 62.80 53.11 Cash & Bank 49.97 30.24 1.44 1.28 3.64 3.15 3.04 3.52 4.38 6.26 Other Current Assets 58.40 5.70 55.72 5.15 64.77 65.18 63.91 22.76 59.77 43.51 Short Term Loans & Adv. 53.39 41.66 60.56 74.83 59.93 65.18 63.91 22.76 59.77 43.51 Net Current Assets 181.80 125.92 67.96 -0.87 25.93 56.22 80.94 69.02 61.08 39.21 Total Assets 577.98 546.82 644.27 732.16 748.49 767.47 834.06 844.80 836.02 729.48

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 440.45 400.28 323.37 332.52 361.91 388.67 437.62 456.68 461.61 379.13 Share Capital 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 11.44 10.54 Total Reserves 427.08 374.19 311.03 320.18 349.57 376.33 426.18 445.24 450.17 363.81 Non-Current Liabilities 45.95 58.12 95.82 136.68 158.47 179.52 212.05 221.55 161.75 147.18 Secured Loans 0.00 0.09 24.19 61.29 86.60 112.69 134.57 150.95 114.76 103.89 Unsecured Loans 38.68 46.74 47.87 54.73 50.84 49.13 56.47 51.34 25.22 25.22 Long Term Provisions 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 3.31 2.91 Current Liabilities 92.74 97.45 224.58 263.62 230.38 196.81 193.14 162.83 210.99 191.25 Trade Payables 54.29 71.36 36.70 36.00 29.33 29.73 25.14 29.56 31.22 18.76 Other Current Liabilities 33.64 21.10 101.70 110.30 78.47 46.16 42.71 15.96 54.70 58.18 Short Term Borrowings 4.06 4.30 85.58 112.80 121.26 119.16 123.32 115.40 110.08 95.68 Short Term Provisions 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 14.99 18.63 Total Liabilities 579.14 555.85 643.77 732.82 750.76 765.00 842.81 841.06 834.35 717.56 Net Block 240.94 261.68 289.37 364.45 389.20 406.18 452.48 443.65 439.46 401.42 Gross Block 612.50 616.32 623.96 707.02 702.77 686.50 679.57 641.12 587.38 511.00 Accumulated Depreciation 371.57 354.63 334.59 342.57 313.57 280.32 227.09 197.47 147.93 109.58 Non Current Assets 301.10 321.82 349.77 467.39 490.50 505.60 565.75 607.85 562.24 491.97 Capital Work in Progress 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 67.80 47.81 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 34.93 35.03 35.77 38.18 36.53 33.17 32.90 85.91 54.98 42.74 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 278.04 234.03 294.00 265.43 260.27 259.41 277.07 233.21 272.11 225.58 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 125.64 119.99 141.12 142.73 138.17 140.60 143.29 142.87 142.26 128.03 Sundry Debtors 38.60 32.04 30.69 38.04 47.27 47.29 61.59 63.22 64.99 47.11 Cash & Bank 50.40 31.42 2.13 2.81 3.98 3.56 7.07 3.62 4.41 6.36 Other Current Assets 63.40 5.70 55.72 5.15 70.84 67.96 65.12 23.51 60.47 44.08 Short Term Loans & Adv. 58.39 44.88 64.34 76.70 66.00 67.96 65.12 23.51 60.47 44.08 Net Current Assets 185.30 136.59 69.43 1.81 29.88 62.59 83.93 70.38 61.12 34.33 Total Assets 579.14 555.85 643.77 732.82 750.77 765.01 842.82 841.06 834.35 717.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 40.90 132.34 77.75 43.65 51.58 61.77 41.91 66.76 52.56 50.66 PBT 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 Adjustment 24.83 21.59 40.39 59.20 64.73 69.30 53.72 81.90 35.95 39.38 Changes in Working Capital -28.60 69.69 20.37 3.75 10.27 17.27 -14.82 -17.18 -49.12 -51.39 Cash after chg. in Working capital 40.90 108.89 63.31 43.65 51.58 61.77 41.91 66.76 52.56 50.66 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -16.65 55.98 -4.64 -11.27 -11.48 -18.06 3.20 -67.15 -93.75 -102.47 Net Fixed Assets 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 Net Investments 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 0.00 0.00 Others -20.07 48.42 -129.06 -6.22 -28.34 -37.01 53.38 0.24 0.02 -0.84 Cash from Financing Activity -9.13 -161.88 -72.35 -34.74 -39.61 -43.60 -45.59 -0.47 39.31 55.15 Net Cash Inflow / Outflow 15.12 26.45 0.76 -2.36 0.49 0.11 -0.48 -0.86 -1.88 3.35 Opening Cash & Equivalents 27.70 0.00 0.50 3.64 3.15 3.04 3.52 4.38 6.26 2.91 Closing Cash & Equivalent 42.83 26.45 1.26 1.28 3.64 3.15 3.04 3.52 4.38 6.26

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 41.00 131.84 77.60 45.33 31.19 58.93 46.88 67.80 52.65 52.15 PBT 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 Adjustment 26.33 21.89 41.56 60.72 66.24 70.61 56.41 83.56 37.21 40.72 Changes in Working Capital -21.74 61.39 20.82 5.37 -7.52 9.96 -13.04 -18.40 -53.65 -51.41 Cash after chg. in Working capital 41.00 108.39 63.16 45.33 31.19 58.93 46.88 67.80 52.65 52.15 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -16.63 56.49 -4.75 -11.33 -11.48 -18.32 2.92 -67.18 -94.66 -103.89 Net Fixed Assets 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 Net Investments 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 0.00 0.00 Others -20.05 48.93 -129.17 -6.28 -28.34 -37.27 53.10 0.21 -0.89 -2.26 Cash from Financing Activity -9.48 -162.24 -73.00 -35.17 -39.23 -44.13 -46.35 -1.42 40.06 55.15 Net Cash Inflow / Outflow 14.90 26.09 -0.15 -1.17 -19.52 -3.51 3.46 -0.79 -1.95 3.41 Opening Cash & Equivalents 28.88 1.94 2.03 3.98 0.00 7.07 3.62 4.41 6.36 2.95 Closing Cash & Equivalent 43.26 28.88 1.94 2.81 -19.52 3.56 7.07 3.62 4.41 6.36

Financial Ratios

Consolidated /

Standalone

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 336.21 313.10 269.21 276.25 298.16 319.42 388.42 407.48 408.51 367.54 ROA 8.71% 9.11% -1.20% -3.66% -3.51% -2.53% 0.14% 0.54% 7.79% 8.68% ROE 11.72% 15.10% -2.44% -7.65% -6.98% -4.83% 0.26% 0.97% 14.26% 16.38% ROCE 9.55% 10.80% 1.15% -0.48% 1.75% 1.50% 5.11% 5.55% 13.40% 14.49% Fixed Asset Turnover 0.99 0.88 0.51 0.45 0.54 0.57 0.63 0.77 1.02 1.04 Receivable days 14.87 16.39 34.86 45.68 44.23 46.56 51.33 49.34 40.15 38.45 Inventory Days 77.84 90.83 158.08 167.43 141.69 134.83 126.05 113.85 92.77 87.83 Payable days 57.28 55.46 42.49 37.63 31.43 27.90 25.33 24.89 20.07 14.84 Cash Conversion Cycle 35.43 51.76 150.45 175.48 154.49 153.50 152.04 138.30 112.85 111.44 Total Debt/Equity 0.09 0.12 0.65 0.86 0.82 0.78 0.74 0.68 0.62 0.70 Interest Cover 0.00 4.23 0.52 -0.12 0.34 0.31 1.08 1.05 3.24 3.56

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 329.50 313.18 262.01 269.42 293.23 314.92 382.47 399.13 403.43 355.10 ROA 7.18% 10.30% -1.45% -3.85% -4.05% -2.12% 0.20% 0.62% 8.29% 8.87% ROE 9.85% 17.40% -3.05% -8.23% -8.18% -4.13% 0.38% 1.12% 15.38% 17.04% ROCE 7.89% 12.37% 0.90% -0.67% 1.17% 2.00% 5.35% 5.74% 14.06% 14.85% Fixed Asset Turnover 0.97 0.88 0.51 0.46 0.54 0.59 0.63 0.76 0.99 1.00 Receivable days 21.54 20.89 36.97 48.37 46.34 49.67 54.45 50.42 37.72 33.88 Inventory Days 74.88 86.94 152.66 159.26 136.61 129.51 124.86 112.15 90.94 87.34 Payable days 59.49 57.86 42.82 37.91 30.30 26.74 26.74 27.25 21.28 15.09 Cash Conversion Cycle 36.93 49.96 146.80 169.72 152.65 152.44 152.57 135.32 107.37 106.14 Total Debt/Equity 0.10 0.13 0.68 0.90 0.85 0.80 0.77 0.70 0.63 0.72 Interest Cover 76.69 4.73 0.40 -0.17 0.23 0.41 1.09 1.06 3.35 3.55

Top Investors:

k.b.shekar

pradeep kumar jain

investor education and protection fund (iepf)

llp

Annual Reports:

News Update:

Venus Remedies gets GMP certification from Ukraine
7th Jun 2023, 12:17 PM

This international GMP approval, the 27th for Venus Remedies, will also enable the company to expand its product portfolio globally
Read More
Venus Remedies secures GMP certification from Kenya for all production facilities in Baddi
23rd May 2023, 12:27 PM

With this, the number of international GMP certifications for Venus Remedies has gone up to 25
Read More
Venus Remedies receives renewal of recognition for in-house R&D excellence by DSIR
16th May 2023, 11:27 AM

The company has consistently invested in research and development
Read More
Venus Remedies secures marketing authorization from UK MHRA for Cisplatin
25th Apr 2023, 15:41 PM

The registration for Cisplatin will also expedite the process of registering the oncology products of Venus Remedies in many other countries
Read More
Venus Remedies receives GMP certification from Saudi Arabia
27th Feb 2023, 10:38 AM

The company has received GMP certification for all its production facilities at its unit in Baddi, Himachal Pradesh
Read More

Venus Remedies Ltd.

Pharmaceuticals & Drugs

BSE: 526953 | NSE: VENUSREM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Venus Remedies Ltd.

Pharmaceuticals & Drugs

BSE: 526953 | NSE: VENUSREM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: